Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Long-Term Investments (2016)

Northwest Biotherapeutics' Long-Term Investments history spans 7 years, with the latest figure at $77000.0 for Q2 2016.

  • Quarterly results put Long-Term Investments at $77000.0 for Q2 2016, down 89.58% from a year ago — trailing twelve months through Jun 2016 was $77000.0 (down 89.58% YoY), and the annual figure for FY2015 was $349000.0, down 80.17%.
  • Long-Term Investments for Q2 2016 was $77000.0 at Northwest Biotherapeutics, down from $214000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $1.8 million in Q4 2014 to a low of $17000.0 in Q4 2012.
  • The 5-year median for Long-Term Investments is $77000.0 (2016), against an average of $394923.1.
  • The sharpest move saw Long-Term Investments skyrocketed 2296.36% in 2015, then tumbled 89.58% in 2016.
  • Year by year, Long-Term Investments stood at $17000.0 in 2012, then changed by 0.0% to $17000.0 in 2013, then soared by 10252.94% to $1.8 million in 2014, then tumbled by 80.17% to $349000.0 in 2015, then crashed by 77.94% to $77000.0 in 2016.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $77000.0, $214000.0, and $349000.0 for Q2 2016, Q1 2016, and Q4 2015 respectively.